188 related articles for article (PubMed ID: 1612232)
1. Islet cell antibodies in normal French schoolchildren.
Lévy-Marchal C; Tichet J; Fajardy I; Gu XF; Dubois F; Czernichow P
Diabetologia; 1992 Jun; 35(6):577-82. PubMed ID: 1612232
[TBL] [Abstract][Full Text] [Related]
2. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
[TBL] [Abstract][Full Text] [Related]
3. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
Williams AJ; Bingley PJ; Moore WP; Gale EA;
Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
[TBL] [Abstract][Full Text] [Related]
4. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
[TBL] [Abstract][Full Text] [Related]
5. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients.
Thivolet C; Beaufrère B; Geburher L; Chatelain P; Orgiazzi J; François R
Diabetologia; 1991 Mar; 34(3):186-91. PubMed ID: 1884891
[TBL] [Abstract][Full Text] [Related]
7. Immunogenetic determinants and prediction of IDDM in French schoolchildren.
Lévy-Marchal C; Dubois F; Noël M; Tichet J; Czernichow P
Diabetes; 1995 Sep; 44(9):1029-32. PubMed ID: 7657024
[TBL] [Abstract][Full Text] [Related]
8. Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.
Bärmeier H; McCulloch DK; Neifing JL; Warnock G; Rajotte RV; Palmer JP; Lernmark A
Diabetologia; 1991 Oct; 34(10):727-33. PubMed ID: 1959705
[TBL] [Abstract][Full Text] [Related]
9. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.
Landin-Olsson M; Karlsson A; Dahlquist G; Blom L; Lernmark A; Sundkvist G
Diabetologia; 1989 Jun; 32(6):387-95. PubMed ID: 2547682
[TBL] [Abstract][Full Text] [Related]
10. Glutamic acid decarboxylase and islet cell antibodies in healthy Estonian children.
Adojaan B; Sabbah E; Vähäsalo P; Akerblom HK; Podar T; Knip M
J Pediatr Endocrinol Metab; 1999; 12(5):667-72. PubMed ID: 10703539
[TBL] [Abstract][Full Text] [Related]
11. On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth.
Ziegler AG; Hillebrand B; Rabl W; Mayrhofer M; Hummel M; Mollenhauer U; Vordemann J; Lenz A; Standl E
Diabetologia; 1993 May; 36(5):402-8. PubMed ID: 8314444
[TBL] [Abstract][Full Text] [Related]
12. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children.
Landin-Olsson M; Palmer JP; Lernmark A; Blom L; Sundkvist G; Nyström L; Dahlquist G
Diabetologia; 1992 Nov; 35(11):1068-73. PubMed ID: 1473617
[TBL] [Abstract][Full Text] [Related]
14. The natural history of pre-type 1 (insulin-dependent) diabetes mellitus in patients with autoimmune endocrine diseases.
Betterle C; Presotto F; Magrin L; Pedini B; Moro L; Caretto A; Zanchetta R
Diabetologia; 1994 Jan; 37(1):95-103. PubMed ID: 8150236
[TBL] [Abstract][Full Text] [Related]
15. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
[TBL] [Abstract][Full Text] [Related]
16. Quantification of human cytoplasmic islet-cell antibodies which cross-react with mouse pancreas: a follow-up study in type 1 (insulin-dependent) diabetic patients and in first-degree relatives.
Saï P; Elmansour A; Audrain M; Charbonnel B; Bardet S
Diabetologia; 1993 Aug; 36(8):778-84. PubMed ID: 8405747
[TBL] [Abstract][Full Text] [Related]
17. Natural history of islet cell antibodies during the clinical period of type 1 diabetes. High titres at diagnosis are associated with longer persistence.
Goday A; Fernandez J; Gonzalez-Clemente JM; Ferrer J; Usach E; Gomis R; Vilardell E
Diabetes Res; 1991 Aug; 17(4):169-74. PubMed ID: 1823637
[TBL] [Abstract][Full Text] [Related]
18. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
Vandewalle CL; Decraene T; Schuit FC; De Leeuw IH; Pipeleers DG; Gorus FK
Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
[TBL] [Abstract][Full Text] [Related]
19. [Risk markers of insulin-dependent diabetes in the normal population].
Levy-Marchal C; Tichet J; Fajardy I; Dubois F; Czernichow P
Ann Endocrinol (Paris); 1992; 53(3):82-5. PubMed ID: 1295436
[TBL] [Abstract][Full Text] [Related]
20. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
